Autopsy report · NCT01632566

A Multiple-dose Study of LY3031207 in Healthy Participants

“Elevation of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in some participants.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 10 months before it stopped.
• 39 participants enrolled.
• Results were posted on the registry 6 years 2 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

Eli Lilly and Company

Sponsor type

Industry

Conditions

Healthy Volunteers

Interventions

Placebo; LY3031207; Celecoxib; Simvastatin

Participants

39

Sites

1

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.